Determination of risperidone and its major metabolite 9-hydroxyrisperidone in human plasma by reversed-phase liquid chromatography with ultraviolet detection.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Chromatography B: Biomedical Sciences and Applications

• Publication date

  2000-09-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0378-4347(00)00323-6PMID 11076069
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Metabolism of risperidone to 9-hydroxyrisperidone by human cytochromes P450 2D6 and 3A4

  1999cited by this paper
• Therapeutic drug monitoring of risperidone using a new, rapid HPLC method: reappraisal of interindividual variability factors.

  1999cited by this paper
• Cytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9-hydroxyrisperidone

  1999cited by this paper
• (S)-ketoprofen accumulation in premature neonates with renal failure who were exposed to the racemate during pregnancy.

  1999cited by this paper
• Antipsychotic agents and bipolar disorder.

  1998cited by this paper
• Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.

  1998cited by this paper
• Plasma Concentrations of Risperidone and its 9-Hydroxy Metabolite and their Relationship to Dose in Schizophrenic Patients: Simultaneous Determination by a High Performance Liquid Chromatography with Electrochemical Detection

  1998cited by this paper
• Serum concentrations and side effects in psychiatric patients during risperidone therapy.

  1998cited by this paper
• Determination of clozapine, desmethylclozapine and clozapine N-oxide in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection.

  1998cited by this paper
• Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in serum from patients comedicated with other psychotropic drugs.

  1997cited by this paper
• Therapeutic drug monitoring of risperidone and 9-hydroxyrisperidone in serum with solid-phase extraction and high-performance liquid chromatography.

  1997cited by this paper
• Risperidone dose and blood level variability: accumulation effects and interindividual and intraindividual variability in the nonresponder patient in the clinical practice setting.

  1997cited by this paper
• Pharmacokinetics and drug interactions: update for new antipsychotics.

  1996cited by this paper
• New developments in the pharmacologic treatment of schizoaffective disorder.

  1996cited by this paper
• Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man

  1995cited by this paper
• Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat

  1994cited by this paper
• Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects

  1993cited by this paper
• Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with electrochemical detection.

  1993cited by this paper
• Absorption, metabolism, and excretion of risperidone in humans.

  1993cited by this paper
• Determination of risperidone and 9-hydroxyrisperidone in plasma, urine and animal tissues by high-performance liquid chromatography.

  1992cited by this paper
• Biochemical profile of risperidone, a new antipsychotic.

  1988cited by this paper

• Guava-fruit based synthesis of carbon quantum dots for spectrofluorometric quantitative analysis of risperidone in spiked human plasma and pharmaceutical dosage forms

  2023cites this paper
• Development of a Highly Sensitive Electrochemical Sensor Using Sm2CuZrO6 Double Perovskite as an Electrocatalyst for Determination of Risperidone Antipsychotic Drug in Tablet Samples

  2023cites this paper
• Dispersive solid phase extraction of risperidone from plasma samples using graphene oxide aerogels and determination with liquid chromatography.

  2023cites this paper
• Condition Optimization for The Analysis of Risperidone and 9-0H-Risperidone by High-Performance Liquid Chromatography

  2022cites this paper
• Development and validation of a reverse phase High Performance Liquid Chromatographic method, using standard addition calibration, for determination of risperidone in human plasma

  2022cites this paper
• Multivesicular liposomal depot system for sustained delivery of risperidone: development, characterization, and toxicity assessment

  2021cites this paper
• Therapeutic Drug Monitoring of Psychotropics as a Diagnostic Tool for CYP2D6 Poor Metabolizer Phenotype

  2021cites this paper
• The gut microbiome influences the bioavailability of olanzapine in rats

  2021cites this paper
• Plasma Concentration of Risperidone: Correlation with Clinical Response in Patients with Schizophrenia

  2021cites this paper
• A Validated Rapid Reversed-Phase High Performance Liquid Chromatographic Method for Determination of Risperidone and Benzoic Acid

  2020cites this paper
• Field-amplified sample injection in capillary zone electrophoresis for the pharmacokinetic research of trace risperidone and its major metabolite 9-hydroxyrisperidone in beagle dogs.

  2020cites this paper
• Bioassay studies of Risperidone and its active metabolite in rat dried blood spots and dried plasma spots using LC‐ESI‐MS/MS: Comparison of their pharmacokinetic profiles

  2020cites this paper
• A fast DLLME-LC-MS/MS method for risperidone and its metabolite 9-hydroxyrisperidone determination in plasma samples for therapeutic drug monitoring of patients

  2020cites this paper
• Quantitative determination of risperidone, paliperidone and olanzapine in human serum by liquid chromatography-tandem mass spectrometry coupled with on-line solid-phase extraction.

  2018cites this paper
• A VALIDATED REVERSE PHASE-HPLC METHOD FOR QUANTIFICATION OF RISPERIDONE IN RAT PLASMA BY PDA DETECTOR

  2018cites this paper
• A NOVEL SENSITIVE AND SELECTIVE POTENTIOMETRIC SENSOR FOR RISPERIDONE DETECTION

  2018cites this paper
• Surface modification of glassy carbon electrode with the functionalized carbon nanotube for ultrasensitive electrochemical detection of risperidone

  2018cites this paper
• A Prospective Study to Evaluate the Effect of CYP2D6 Polymorphism on Plasma level of Risperidone and its Metabolite in North Indian Patients with Schizophrenia

  2018cites this paper
• Enantioselective supercritical fluid chromatography-tandem mass spectrometry method for simultaneous estimation of risperidone and its 9-hydroxyl metabolites in rat plasma.

  2017cites this paper
• New Modified UPLC/Tandem Mass Spectrometry Method for Determination of Risperidone and Its Active Metabolite 9-Hydroxyrisperidone in Plasma: Application to Dose-Dependent Pharmacokinetic Study in Sprague-Dawley Rats

  2017cites this paper
• Suivi pharmacologique des formes injectables à action prolongée de rispéridone et de palipéridone : étude des concentrations et intérêt clinique

  2017cites this paper
• Low-Dose of Bergamot-Derived Polyphenolic Fraction (BPF) Did Not Improve Metabolic Parameters in Second Generation Antipsychotics-Treated Patients: Results from a 60-days Open-Label Study

  2017cites this paper
• LC-MS/MS Method for the Estimation of Paliperidone in Human Plasma

  2017cites this paper
• UPLC-Tandem Mass Spectrometry Method for Simultaneous Determination of Fluoxetine, Risperidone, and Its Active Metabolite 9-Hydroxyrisperidone in Plasma: Application to Pharmacokinetics Study in Rats

  2017cites this paper
• Development and Validation of Liquid Chromatography/Tandem Mass Spectrometry Analysis for Therapeutic Drug Monitoring of Risperidone and 9‐Hydroxyrisperidone in Pediatric Patients with Autism Spectrum Disorders

  2016cites this paper
• Use of high‐conductivity sample solution with sweeping‐micellar electrokinetic capillary chromatography for trace‐level quantification of paliperidone in human plasma

  2015cites this paper
• Forced degradation studies, and effect of surfactants and titanium dioxide on the photostability of paliperidone by HPLC.

  2015cites this paper
• DEVELOPMENT AND VALIDATION OF RAPID UHPLC METHOD FOR DETERMINATION OF RISPERIDONE AND ITS IMPURITIES IN BULK POWDER AND TABLETS

  2014cites this paper
• Cyclic voltammetry characteristics of the portable electrochemical system in comparison with IM6ex workstation

  2014cites this paper
• Phytochemical and Pharmacological Investigation of Ethanol Extract of Cissampelos pareira

  2014cites this paper
• Spectrophotometric Estimation of Risperidone in Tablets

  2014cites this paper
• CYP2D6 genotyping in paediatric patients with autism treated with risperidone: a preliminary cohort study

  2014cites this paper
• Development and validation of a rapid and sensitive UHPLC–MS/MS method for the determination of paliperidone in beagle dog plasma

  2014cites this paper
• Formulation, in vitro and in vivo evaluation of transdermal patches containing risperidone

  2013cites this paper
• Monitorización de niveles plasma de antipsicóticos atípicos

  2012cites this paper
• Multiwalled carbon nanotube paste electrode as an easy, inexpensive and highly selective sensor for voltammetric determination of Risperidone

  2012cites this paper
• Active metabolites resulting from decarboxylation, reduction and ester hydrolysis of parent drugs.

  2012cites this paper
• Chapter 8 – Risperidone

  2012cites this paper
• Therapeutic Drug Monitoring of Common Antipsychotics

  2012cites this paper
• Use of the Charge Transfer Reactions for the Spectrophotometric Determination of Risperidone in Pure and in Dosage Forms

  2012cites this paper
• Comparative pharmacokinetics and bioequivalence of two tablet formulations of 2 mg risperidone in healthy Thai male volunteers.

  2011cites this paper
• A stability indicating HPLC method for the determination of electrochemically controlled release of risperidone.

  2011cites this paper
• Aliphatic and aromatic oxidations, epoxidation and S-oxidation of prodrugs that yield active drug metabolites.

  2011cites this paper
• Square-wave cathodic adsorptive stripping voltammetry of risperidone

  2011cites this paper
• Risperidone in Schizophrenia: Is There a Role for Therapeutic Drug Monitoring?

  2011cites this paper
• Analysis of risperidone and its metabolite in plasma and saliva by LC with coulometric detection and a novel MEPS procedure.

  2010cites this paper
• In vitro monitoring of picogram levels of risperidone in human urine via luminollysozyme flow injection chemiluminescence

  2010cites this paper
• HPTLc method development and validation for analysis of risperidone in formulations, and in-vitro release study

  2010cites this paper
• Accuracy Profile Theory for the Validation of an LC–MS-MS Method for the Determination of Risperidone and 9-Hydroxyrisperidone in Human Plasma

  2010cites this paper
• Development of a Novel Drug Delivery System Based on Conducting Polymers

  2010cites this paper
• Chronic olanzapine, serotonin receptors, and subsequent serotonin toxicity.

  2010cites this paper
• Relative bioavailability of two oral formulations of risperidone 2 mg: A single-dose, randomized-sequence, open-label, two-period crossover comparison in healthy Brazilian volunteers.

  2010cites this paper
• Physicochemical characterization of neuroleptics. Relative stability of 7- and 9-hydroxyrisperidones and their protonated forms in gas phase and in solution.

  2010cites this paper
• Effect of adjunctive duloxetine on the plasma concentrations of clozapine, olanzapine, and risperidone in patients with psychotic disorders.

  2010cites this paper
• Antipsychotic and antiepileptic drugs in bipolar disorder: the importance of therapeutic drug monitoring.

  2009cites this paper
• Determination of risperidone and 9-Hydroxyrisperidone using HPLC, in plasma of children and adolescents with emotional and behavioural disorders.

  2009cites this paper
• Short- and long-term effects on prolactin of risperidone and olanzapine treatments in children and adolescents.

  2009cites this paper
• Simultaneous determination of risperidone and 9-hydroxyrisperidone enantiomers in human blood plasma by liquid chromatography with electrochemical detection.

  2009cites this paper
• Serum Levels of Risperidone and Its Metabolite, 9-Hydroxyrisperidone: Correlation Between Drug Concentration and Clinical Response

  2009cites this paper
• Identification, isolation and characterization of potential degradation product in risperidone tablets.

  2008cites this paper
• Bioequivalence study of a generic Risperidone (Iperdal fi ) in healthy Thai male volunteers

  2008influential citation
• UNIVERSITATIS UPSALIENSIS UPPSALA 2008 Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 335 Pharmacogenetics and Antipsychotic Treatment in Schizophrenia with Special Focus on Adverse Drug Reactions

  2008cites this paper
• Non-destructive quantitative analysis of risperidone in film-coated tablets.

  2008cites this paper
• Bicyclic 6-6 systems with one bridgehead (ring junction) nitrogen atom: One extra heteroatom 1:0

  2008cites this paper
• Semi-quantitative CYP2D6 gene doses in relation to metabolic ratios of psychotropics

  2008cites this paper
• Clinical Significance of a CYP2D6 Poor Metabolizer -A Patient With Schizophrenia on Risperidone Treatment

  2008cites this paper
• ABCB1 Polymorphisms Influence Steady-State Plasma Levels of 9-Hydroxyrisperidone and Risperidone Active Moiety

  2008cites this paper
• Validated LC-MS/MS methods for the determination of risperidone and the enantiomers of 9-hydroxyrisperidone in human plasma and urine.

  2008cites this paper
• High‐Performance Liquid Chromatographic Analysis of Psychotropic and Endogenous Compounds

  2007cites this paper
• Effect of Topiramate on Plasma Concentrations of Clozapine, Olanzapine, Risperidone, and Quetiapine in Patients With Psychotic Disorders

  2007cites this paper
• Determination of risperidone and enantiomers of 9-hydroxyrisperidone in plasma by LC-MS/MS.

  2007cites this paper
• Rifampin, a cytochrome P450 3A inducer, decreases plasma concentrations of antipsychotic risperidone in healthy volunteers

  2007cites this paper
• Turbulent flow and ternary column-switching on-line clean-up system for high-throughput quantification of risperidone and its main metabolite in plasma by LC-MS/MS: application to a bioequivalence study.

  2007cites this paper
• PHARMACOGENETICS OF CYP2D6: CLINICAL IMPLICATIONS IN PSYCHIATRIC PATIENTS TREATED WITH ANTIPSYCHOTIC DRUGS

  2007cites this paper
• Optimization of the separation of some psychotropic drugs and their respective metabolites by liquid chromatography.

  2006cites this paper
• Effect of Adjunctive Lamotrigine Treatment on the Plasma Concentrations of Clozapine, Risperidone and Olanzapine in Patients With Schizophrenia or Bipolar Disorder

  2006cites this paper
• Rapid High Performance Liquid Chromatographic Determination of Risperidone in Human Plasma

  2006cites this paper
• EffectofAdjunctiveLamotrigineTreatmentonthePlasma ConcentrationsofClozapine,RisperidoneandOlanzapine in Patients With Schizophrenia or Bipolar Disorder

  2006cites this paper
• Structural studies of impurities of risperidone by hyphenated techniques.

  2006cites this paper
• Liquid chromatography/tandem mass spectrometry method for simultaneous determination of risperidone and its active metabolite 9-hydroxyrisperidone in human plasma.

  2006cites this paper
• HPLC-DAD determination of plasma levels of the antipsychotic risperidone and its main metabolite for toxicological purposes.

  2005cites this paper
• High performance liquid chromatographic and thin layer densitometric methods for the determination of risperidone in the presence of its degradation products in bulk powder and in tablets.

  2005cites this paper
• Plasma Concentrations of Risperidone and Olanzapine during Coadministration with Oxcarbazepine

  2005cites this paper
• Effect of fluvoxamine on plasma risperidone concentrations in patients with schizophrenia.

  2005cites this paper
• Metabolic Ratios of Psychotropics as Indication of Cytochrome P450 2D6/2C19 Genotype

  2005cites this paper
• Chapter 2 - Chromatographic methods for the analysis of drugs in biological fluids

  2004cites this paper
• Identification and characterization of major degradation products of risperidone in bulk drug and pharmaceutical dosage forms.

  2004cites this paper
• Atypical antipsychotics: pharmacokinetics, therapeutic drug monitoring and pharmacological interactions.

  2004cites this paper
• Risperidone Treatment of Children with Autistic Disorder: Effectiveness, Tolerability, and Pharmacokinetic Implications

  2004cites this paper
• Toxikologisches Monitoring von Risperidon und Lithium bei einer akuten Intoxikation

  2004cites this paper
• The role of cytochrome P450 enzymes in the metabolism of risperidone and its clinical relevance for drug interactions.

  2004cites this paper
• Sensitive chemiluminescence assay for risperidone in pharmaceutical preparations.

  2004cites this paper
• Plasma Risperidone Concentrations During Combined Treatment with Sertraline

  2004cites this paper
• Recent Development in the Chemistry of Pyrido-oxazines, Pyrido-thiazines, Pyrido-diazines and Their

  2003cites this paper
• The effect of smoking and cytochrome P450 CYP1A2 genetic polymorphism on clozapine clearance and dose requirement.

  2003cites this paper
• Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia.

  2003cites this paper
• Validated method for the determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography-tandem mass spectrometry.

  2003cites this paper
• Analysis of eighteen antidepressants, four atypical antipsychotics and active metabolites in serum by liquid chromatography: a simple tool for therapeutic drug monitoring.

  2003cites this paper
• Screening, library-assisted identification and validated quantification of fifteen neuroleptics and three of their metabolites in plasma by liquid chromatography/mass spectrometry with atmospheric pressure chemical ionization.

  2003cites this paper
• Determination of risperidone and 9-hydroxyrisperidone in human plasma by liquid chromatography: application to the evaluation of CYP2D6 drug interactions.

  2003cites this paper